Literature DB >> 6501568

Role of thrombospondin in platelet aggregation.

L L Leung.   

Abstract

Thrombospondin (TSP), the major alpha-granule protein of human platelets, binds to the activated platelet surface upon platelet stimulation. TSP has hemagglutinating (lectin-like) activity and forms a specific complex with fibrinogen. Based on these observations, it was postulated that the interaction of TSP and fibrinogen on the activated platelet surface may be an important step in the platelet aggregation process. To test this hypothesis, monospecific, affinity-purified anti-TSP Fab fragments were prepared and their effects on platelet aggregation and platelet fibrinogen binding were studied. Anti-TSP Fab caused significant interference with thrombin- and collagen-induced platelet aggregation, as monitored by both turbidometric aggregometry and particle counting measuring the disappearance of single platelets. Phase-contrast microscopy revealed that anti-TSP Fab caused a marked decrease in platelet macroaggregates and an increase in microaggregates and nonaggregated single platelets. Anti-TSP Fab did not affect the initial phase of ADP-induced platelet aggregation but caused rapid platelet disaggregation with the abolition of the secondary phase of aggregation. The effect of anti-TSP Fab was not mediated by a direct inhibition of platelet secretion. The effect of anti-TSP Fab on specific binding of labeled fibrinogen to thrombin-stimulated platelets was also studied. Anti-TSP Fab caused a marked decrease in the affinity of fibrinogen binding to the receptors on the activated platelet surface. Kinetic analyses revealed significant displacement of labeled fibrinogen by unlabeled fibrinogen in the presence of anti-TSP Fab, suggesting that TSP serves to stabilize fibrinogen binding to the activated platelet surface and reinforces the strength of interplatelet interactions. It is proposed that platelet aggregation is a dynamic, multistep process, governed initially by the platelet membrane glycoprotein IIb/IIIa-fibrinogen interaction, with the TSP-fibrinogen interaction playing an important role in determining the size and reversibility of platelet aggregates.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501568      PMCID: PMC425356          DOI: 10.1172/JCI111595

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.

Authors:  J W Lawler; H S Slayter; J E Coligan
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

2.  Effects of thrombin on washed, human platelets: changes in the subcellular fractions.

Authors:  I Hagen
Journal:  Biochim Biophys Acta       Date:  1975-06-12

3.  Theory of protein-ligand interaction.

Authors:  D Rodbard; H A Feldman
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

Review 4.  The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets.

Authors:  A T Nurden; J P Caen
Journal:  Semin Hematol       Date:  1979-07       Impact factor: 3.851

5.  A thrombin-sensitive protein of human platelet membranes.

Authors:  N L Baenziger; G N Brodie; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1971-01       Impact factor: 11.205

6.  D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin.

Authors:  C Kettner; E Shaw
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

7.  Purification and binding properties of human platelet factor four.

Authors:  R I Handin; H J Cohen
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

8.  Factors responsible for ADP-induced release reaction of human platelets.

Authors:  J F Mustard; D W Perry; R L Kinlough-Rathbone; M A Packham
Journal:  Am J Physiol       Date:  1975-06

9.  Formation of prostaglandins during the aggregation of human blood platelets.

Authors:  J B Smith; C Ingerman; J J Kocsis; M J Silver
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

10.  Thrombin-induced platelet aggregation is mediated by a platelet plasma membrane-bound lectin.

Authors:  T K Gartner; D C Williams; F C Minion; D R Phillips
Journal:  Science       Date:  1978-06-16       Impact factor: 47.728

View more
  55 in total

Review 1.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Immunoelectron-microscopic studies of human platelet thrombospondin, von Willebrand factor, and fibrinogen redistribution during clot formation.

Authors:  S C Watkins; V Raso; H S Slayter
Journal:  Histochem J       Date:  1990-09

Review 3.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

4.  Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.

Authors:  N Kieffer; J Guichard; J Breton-Gorius
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

5.  Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Authors:  Arnaud Bonnefoy; Kim Daenens; Hendrik B Feys; Rita De Vos; Petra Vandervoort; Jos Vermylen; Jack Lawler; Marc F Hoylaerts
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

6.  Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.

Authors:  F R Agbanyo; J J Sixma; P G de Groot; L R Languino; E F Plow
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum.

Authors:  A E Canfield; R P Boot-Handford; A M Schor
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

8.  Thrombin and thrombin receptor agonist peptide induce tyrosine phosphorylation and tyrosine kinases in the platelet cytoskeleton. Translocation of pp60c-src and integrin alpha IIb beta 3 (glycoprotein IIb/IIIa) is not required for aggregation, but is dependent on formation of large aggregate structures.

Authors:  K M Pumiglia; M B Feinstein
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

Review 9.  The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.

Authors:  Anguo Liu; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Microvasc Res       Date:  2008-10-01       Impact factor: 3.514

10.  Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator.

Authors:  R L Silverstein; L L Leung; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.